APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rabies Antiserum

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Rabies Antiserum Market Analysis and Forecast 2026-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchRabies Antiserum Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Rabies Antiserum Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Rabies Antiserum Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rabies Antiserum Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Rabies Antiserum Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Rabies Antiserum market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Rabies Antiserum is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Rabies Antiserum is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Rabies Antiserum is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Rabies Antiserum is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Rabies Antiserum include Bharat Serums, Haffkine Bio-Pharmaceutical, Premium Serums, Lanzhou Institute of Biological Products, Serum China and Wuhan Institute of Biological Products, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Rabies Antiserum, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Rabies Antiserum, also provides the sales of main regions and countries. Of the upcoming market potential for Rabies Antiserum, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rabies Antiserum sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rabies Antiserum market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Rabies Antiserum sales, projected growth trends, production technology, application and end-user industry.

Rabies Antiserum Segment by Company

Bharat Serums

Haffkine Bio-Pharmaceutical

Premium Serums

Lanzhou Institute of Biological Products

Serum China

Wuhan Institute of Biological Products

Rabies Antiserum Segment by Type

400IU

1500IU

1000IU

Other

Rabies Antiserum Segment by Application

Category II Exposure

Category III Exposure

Rabies Antiserum Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Antiserum market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rabies Antiserum and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Antiserum.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Rabies Antiserum in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Rabies Antiserum manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rabies Antiserum sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rabies Antiserum Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 400IU Major Manufacturers Table 3. 1500IU Major Manufacturers Table 4. 1000IU Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Rabies Antiserum Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Category II Exposure Major Manufacturers Table 8. Category III Exposure Major Manufacturers Table 9. Rabies Antiserum Industry Trends Table 10. Rabies Antiserum Industry Drivers Table 11. Rabies Antiserum Industry Opportunities and Challenges Table 12. Rabies Antiserum Industry Restraints Table 13. Global Rabies Antiserum Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Rabies Antiserum Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Rabies Antiserum Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Rabies Antiserum Revenue Market Share by Region (2021-2026) Table 17. Global Rabies Antiserum Revenue Market Share by Region (2027-2032) Table 18. Global Rabies Antiserum Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Tons) Table 19. Global Rabies Antiserum Sales by Region (2021-2026) & (K Tons) Table 20. Global Rabies Antiserum Sales by Region (2027-2032) & (K Tons) Table 21. Global Rabies Antiserum Sales Market Share by Region (2021-2026) Table 22. Global Rabies Antiserum Sales Market Share by Region (2027-2032) Table 23. Global Rabies Antiserum Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Rabies Antiserum Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Rabies Antiserum Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Rabies Antiserum Sales Market Share by Manufacturers (2021-2026) Table 27. Global Rabies Antiserum Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 28. Global Rabies Antiserum Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Rabies Antiserum Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Rabies Antiserum Manufacturers, Product Type & Application Table 31. Global Rabies Antiserum Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Rabies Antiserum by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Rabies Antiserum Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Rabies Antiserum Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Rabies Antiserum Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Rabies Antiserum Revenue Market Share by Type (2021-2026) Table 38. Global Rabies Antiserum Revenue Market Share by Type (2027-2032) Table 39. Global Rabies Antiserum Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 40. Global Rabies Antiserum Sales by Type (2021-2026) & (K Tons) Table 41. Global Rabies Antiserum Sales by Type (2027-2032) & (K Tons) Table 42. Global Rabies Antiserum Sales Market Share by Type (2021-2026) Table 43. Global Rabies Antiserum Sales Market Share by Type (2027-2032) Table 44. Global Rabies Antiserum Price by Type (2021-2026) & (US$/Ton) Table 45. Global Rabies Antiserum Price by Type (2027-2032) & (US$/Ton) Table 46. Global Rabies Antiserum Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Rabies Antiserum Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Rabies Antiserum Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Rabies Antiserum Revenue Market Share by Application (2021-2026) Table 50. Global Rabies Antiserum Revenue Market Share by Application (2027-2032) Table 51. Global Rabies Antiserum Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 52. Global Rabies Antiserum Sales by Application (2021-2026) & (K Tons) Table 53. Global Rabies Antiserum Sales by Application (2027-2032) & (K Tons) Table 54. Global Rabies Antiserum Sales Market Share by Application (2021-2026) Table 55. Global Rabies Antiserum Sales Market Share by Application (2027-2032) Table 56. Global Rabies Antiserum Price by Application (2021-2026) & (US$/Ton) Table 57. Global Rabies Antiserum Price by Application (2027-2032) & (US$/Ton) Table 58. Bharat Serums Company Information Table 59. Bharat Serums Business Overview Table 60. Bharat Serums Rabies Antiserum Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Bharat Serums Rabies Antiserum Product Portfolio Table 62. Bharat Serums Recent Development Table 63. Haffkine Bio-Pharmaceutical Company Information Table 64. Haffkine Bio-Pharmaceutical Business Overview Table 65. Haffkine Bio-Pharmaceutical Rabies Antiserum Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Haffkine Bio-Pharmaceutical Rabies Antiserum Product Portfolio Table 67. Haffkine Bio-Pharmaceutical Recent Development Table 68. Premium Serums Company Information Table 69. Premium Serums Business Overview Table 70. Premium Serums Rabies Antiserum Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Premium Serums Rabies Antiserum Product Portfolio Table 72. Premium Serums Recent Development Table 73. Lanzhou Institute of Biological Products Company Information Table 74. Lanzhou Institute of Biological Products Business Overview Table 75. Lanzhou Institute of Biological Products Rabies Antiserum Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Lanzhou Institute of Biological Products Rabies Antiserum Product Portfolio Table 77. Lanzhou Institute of Biological Products Recent Development Table 78. Serum China Company Information Table 79. Serum China Business Overview Table 80. Serum China Rabies Antiserum Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Serum China Rabies Antiserum Product Portfolio Table 82. Serum China Recent Development Table 83. Wuhan Institute of Biological Products Company Information Table 84. Wuhan Institute of Biological Products Business Overview Table 85. Wuhan Institute of Biological Products Rabies Antiserum Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Wuhan Institute of Biological Products Rabies Antiserum Product Portfolio Table 87. Wuhan Institute of Biological Products Recent Development Table 88. North America Rabies Antiserum Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Rabies Antiserum Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Rabies Antiserum Sales by Type (2021-2026) & (K Tons) Table 91. North America Rabies Antiserum Sales by Type (2027-2032) & (K Tons) Table 92. North America Rabies Antiserum Sales Price by Type (2021-2026) & (US$/Ton) Table 93. North America Rabies Antiserum Sales Price by Type (2027-2032) & (US$/Ton) Table 94. North America Rabies Antiserum Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Rabies Antiserum Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Rabies Antiserum Sales by Application (2021-2026) & (K Tons) Table 97. North America Rabies Antiserum Sales by Application (2027-2032) & (K Tons) Table 98. North America Rabies Antiserum Sales Price by Application (2021-2026) & (US$/Ton) Table 99. North America Rabies Antiserum Sales Price by Application (2027-2032) & (US$/Ton) Table 100. North America Rabies Antiserum Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Rabies Antiserum Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Rabies Antiserum Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Rabies Antiserum Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 104. North America Rabies Antiserum Sales by Country (2021-2026) & (K Tons) Table 105. North America Rabies Antiserum Sales by Country (2027-2032) & (K Tons) Table 106. North America Rabies Antiserum Sales Price by Country (2021-2026) & (US$/Ton) Table 107. North America Rabies Antiserum Sales Price by Country (2027-2032) & (US$/Ton) Table 108. United States Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 109. Canada Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 110. Europe Rabies Antiserum Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Rabies Antiserum Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Rabies Antiserum Sales by Type (2021-2026) & (K Tons) Table 113. Europe Rabies Antiserum Sales by Type (2027-2032) & (K Tons) Table 114. Europe Rabies Antiserum Sales Price by Type (2021-2026) & (US$/Ton) Table 115. Europe Rabies Antiserum Sales Price by Type (2027-2032) & (US$/Ton) Table 116. Europe Rabies Antiserum Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Rabies Antiserum Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Rabies Antiserum Sales by Application (2021-2026) & (K Tons) Table 119. Europe Rabies Antiserum Sales by Application (2027-2032) & (K Tons) Table 120. Europe Rabies Antiserum Sales Price by Application (2021-2026) & (US$/Ton) Table 121. Europe Rabies Antiserum Sales Price by Application (2027-2032) & (US$/Ton) Table 122. Europe Rabies Antiserum Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Rabies Antiserum Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Rabies Antiserum Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Rabies Antiserum Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 126. Europe Rabies Antiserum Sales by Country (2021-2026) & (K Tons) Table 127. Europe Rabies Antiserum Sales by Country (2027-2032) & (K Tons) Table 128. Europe Rabies Antiserum Sales Price by Country (2021-2026) & (US$/Ton) Table 129. Europe Rabies Antiserum Sales Price by Country (2027-2032) & (US$/Ton) Table 130. Germany Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 131. France Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 132. U.K. Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 133. Italy Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 134. Netherlands Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 135. China Rabies Antiserum Revenue by Type (2021-2026) & (US$ Million) Table 136. China Rabies Antiserum Revenue by Type (2027-2032) & (US$ Million) Table 137. China Rabies Antiserum Sales by Type (2021-2026) & (K Tons) Table 138. China Rabies Antiserum Sales by Type (2027-2032) & (K Tons) Table 139. China Rabies Antiserum Sales Price by Type (2021-2026) & (US$/Ton) Table 140. China Rabies Antiserum Sales Price by Type (2027-2032) & (US$/Ton) Table 141. China Rabies Antiserum Revenue by Application (2021-2026) & (US$ Million) Table 142. China Rabies Antiserum Revenue by Application (2027-2032) & (US$ Million) Table 143. China Rabies Antiserum Sales by Application (2021-2026) & (K Tons) Table 144. China Rabies Antiserum Sales by Application (2027-2032) & (K Tons) Table 145. China Rabies Antiserum Sales Price by Application (2021-2026) & (US$/Ton) Table 146. China Rabies Antiserum Sales Price by Application (2027-2032) & (US$/Ton) Table 147. Asia Rabies Antiserum Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Rabies Antiserum Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Rabies Antiserum Sales by Type (2021-2026) & (K Tons) Table 150. Asia Rabies Antiserum Sales by Type (2027-2032) & (K Tons) Table 151. Asia Rabies Antiserum Sales Price by Type (2021-2026) & (US$/Ton) Table 152. Asia Rabies Antiserum Sales Price by Type (2027-2032) & (US$/Ton) Table 153. Asia Rabies Antiserum Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Rabies Antiserum Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Rabies Antiserum Sales by Application (2021-2026) & (K Tons) Table 156. Asia Rabies Antiserum Sales by Application (2027-2032) & (K Tons) Table 157. Asia Rabies Antiserum Sales Price by Application (2021-2026) & (US$/Ton) Table 158. Asia Rabies Antiserum Sales Price by Application (2027-2032) & (US$/Ton) Table 159. Asia Rabies Antiserum Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Rabies Antiserum Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Rabies Antiserum Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Rabies Antiserum Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 163. Asia Rabies Antiserum Sales by Country (2021-2026) & (K Tons) Table 164. Asia Rabies Antiserum Sales by Country (2027-2032) & (K Tons) Table 165. Asia Rabies Antiserum Sales Price by Country (2021-2026) & (US$/Ton) Table 166. Asia Rabies Antiserum Sales Price by Country (2027-2032) & (US$/Ton) Table 167. Japan Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 168. South Korea Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 169. India Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 170. Australia Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 171. China Taiwan Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Rabies Antiserum Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Rabies Antiserum Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Rabies Antiserum Sales by Type (2021-2026) & (K Tons) Table 176. SAMEA Rabies Antiserum Sales by Type (2027-2032) & (K Tons) Table 177. SAMEA Rabies Antiserum Sales Price by Type (2021-2026) & (US$/Ton) Table 178. SAMEA Rabies Antiserum Sales Price by Type (2027-2032) & (US$/Ton) Table 179. SAMEA Rabies Antiserum Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Rabies Antiserum Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Rabies Antiserum Sales by Application (2021-2026) & (K Tons) Table 182. SAMEA Rabies Antiserum Sales by Application (2027-2032) & (K Tons) Table 183. SAMEA Rabies Antiserum Sales Price by Application (2021-2026) & (US$/Ton) Table 184. SAMEA Rabies Antiserum Sales Price by Application (2027-2032) & (US$/Ton) Table 185. SAMEA Rabies Antiserum Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Rabies Antiserum Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Rabies Antiserum Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Rabies Antiserum Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 189. SAMEA Rabies Antiserum Sales by Country (2021-2026) & (K Tons) Table 190. SAMEA Rabies Antiserum Sales by Country (2027-2032) & (K Tons) Table 191. SAMEA Rabies Antiserum Sales Price by Country (2021-2026) & (US$/Ton) Table 192. SAMEA Rabies Antiserum Sales Price by Country (2027-2032) & (US$/Ton) Table 193. Brazil Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 194. Argentina Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 195. Chile Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 196. Colombia Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 197. Peru Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 199. Israel Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 200. UAE Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 201. Turkey Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 202. Iran Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 203. Egypt Rabies Antiserum Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Rabies Antiserum Distributors List Table 207. Rabies Antiserum Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Rabies Antiserum Image Figure 2. Global Rabies Antiserum Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rabies Antiserum Market Size Share 2021 VS 2025 VS 2032 Figure 4. 400IU Image Figure 5. 1500IU Image Figure 6. 1000IU Image Figure 7. Other Image Figure 8. Global Rabies Antiserum Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Rabies Antiserum Market Size Share 2021 VS 2025 VS 2032 Figure 10. Category II Exposure Image Figure 11. Category III Exposure Image Figure 12. Global Rabies Antiserum Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Rabies Antiserum Revenue (2021-2032) & (US$ Million) Figure 14. Global Rabies Antiserum Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Rabies Antiserum Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Rabies Antiserum Revenue Market Share by Region (2021-2032) Figure 17. Global Rabies Antiserum Sales (2021-2032) & (K Tons) Figure 18. Global Rabies Antiserum Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 19. Global Rabies Antiserum Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Rabies Antiserum Sales YoY (2021-2032) & (K Tons) Figure 21. Europe Rabies Antiserum Sales YoY (2021-2032) & (K Tons) Figure 22. China Rabies Antiserum Sales YoY (2021-2032) & (K Tons) Figure 23. Asia (Excluding China) Rabies Antiserum Sales YoY (2021-2032) & (K Tons) Figure 24. South America, Middle East and Africa Rabies Antiserum Sales YoY (2021-2032) & (K Tons) Figure 25. Global Rabies Antiserum Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Rabies Antiserum Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Rabies Antiserum Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Rabies Antiserum Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Rabies Antiserum Revenue Market Share by Type (2021-2032) Figure 31. Global Rabies Antiserum Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 32. Global Rabies Antiserum Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Rabies Antiserum Sales Market Share by Type (2021-2032) Figure 34. Global Rabies Antiserum Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Rabies Antiserum Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Rabies Antiserum Revenue Market Share by Application (2021-2032) Figure 37. Global Rabies Antiserum Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 38. Global Rabies Antiserum Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Rabies Antiserum Sales Market Share by Application (2021-2032) Figure 40. North America Rabies Antiserum Revenue Share by Type (2021-2032) Figure 41. North America Rabies Antiserum Sales Share by Type (2021-2032) Figure 42. North America Rabies Antiserum Revenue Share by Application (2021-2032) Figure 43. North America Rabies Antiserum Sales Share by Application (2021-2032) Figure 44. North America Rabies Antiserum Revenue Share by Country (2021-2032) Figure 45. North America Rabies Antiserum Sales Share by Country (2021-2032) Figure 46. Europe Rabies Antiserum Revenue Share by Type (2021-2032) Figure 47. Europe Rabies Antiserum Sales Share by Type (2021-2032) Figure 48. Europe Rabies Antiserum Revenue Share by Application (2021-2032) Figure 49. Europe Rabies Antiserum Sales Share by Application (2021-2032) Figure 50. Europe Rabies Antiserum Revenue Share by Country (2021-2032) Figure 51. Europe Rabies Antiserum Sales Share by Country (2021-2032) Figure 52. China Rabies Antiserum Revenue Share by Type (2021-2032) Figure 53. China Rabies Antiserum Sales Share by Type (2021-2032) Figure 54. China Rabies Antiserum Revenue Share by Application (2021-2032) Figure 55. China Rabies Antiserum Sales Share by Application (2021-2032) Figure 56. Asia Rabies Antiserum Revenue Share by Type (2021-2032) Figure 57. Asia Rabies Antiserum Sales Share by Type (2021-2032) Figure 58. Asia Rabies Antiserum Revenue Share by Application (2021-2032) Figure 59. Asia Rabies Antiserum Sales Share by Application (2021-2032) Figure 60. Asia Rabies Antiserum Revenue Share by Country (2021-2032) Figure 61. Asia Rabies Antiserum Sales Share by Country (2021-2032) Figure 62. SAMEA Rabies Antiserum Revenue Share by Type (2021-2032) Figure 63. SAMEA Rabies Antiserum Sales Share by Type (2021-2032) Figure 64. SAMEA Rabies Antiserum Revenue Share by Application (2021-2032) Figure 65. SAMEA Rabies Antiserum Sales Share by Application (2021-2032) Figure 66. SAMEA Rabies Antiserum Revenue Share by Country (2021-2032) Figure 67. SAMEA Rabies Antiserum Sales Share by Country (2021-2032) Figure 68. Rabies Antiserum Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Rabies Antiserum Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 400IU
  • 1500IU
  • 1000IU
  • Other
Applications
  • Category II Exposure
  • Category III Exposure
Companies covered
  • Bharat Serums
  • Haffkine Bio-Pharmaceutical
  • Premium Serums
  • Lanzhou Institute of Biological Products
  • Serum China
  • Wuhan Institute of Biological Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rabies Antiserum Market by Type
  3. 1.2.1 Global Rabies Antiserum Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 400IU
  5. 1.2.3 1500IU
  6. 1.2.4 1000IU
  7. 1.2.5 Other
  8. 1.3 Rabies Antiserum Market by Application
  9. 1.3.1 Global Rabies Antiserum Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Category II Exposure
  11. 1.3.3 Category III Exposure
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Rabies Antiserum Market Dynamics
  1. 2.1 Rabies Antiserum Industry Trends
  2. 2.2 Rabies Antiserum Industry Drivers
  3. 2.3 Rabies Antiserum Industry Opportunities and Challenges
  4. 2.4 Rabies Antiserum Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Rabies Antiserum Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Rabies Antiserum Revenue by Region
  3. 3.2.1 Global Rabies Antiserum Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rabies Antiserum Revenue by Region (2021-2026)
  5. 3.2.3 Global Rabies Antiserum Revenue by Region (2027-2032)
  6. 3.2.4 Global Rabies Antiserum Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Rabies Antiserum Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Rabies Antiserum Sales by Region
  9. 3.4.1 Global Rabies Antiserum Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Rabies Antiserum Sales by Region (2021-2026)
  11. 3.4.3 Global Rabies Antiserum Sales by Region (2027-2032)
  12. 3.4.4 Global Rabies Antiserum Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Rabies Antiserum Revenue by Manufacturers
  2. 4.1.1 Global Rabies Antiserum Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Rabies Antiserum Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Rabies Antiserum Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rabies Antiserum Sales by Manufacturers
  6. 4.2.1 Global Rabies Antiserum Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Rabies Antiserum Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Rabies Antiserum Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Rabies Antiserum Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Rabies Antiserum Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Rabies Antiserum Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Rabies Antiserum Manufacturers, Product Type & Application
  13. 4.7 Global Rabies Antiserum Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Rabies Antiserum Market CR5 and HHI
  16. 4.8.2 2025 Rabies Antiserum Tier 1, Tier 2, and Tier 3
5 Rabies Antiserum Market by Type
  1. 5.1 Global Rabies Antiserum Revenue by Type
  2. 5.1.1 Global Rabies Antiserum Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Rabies Antiserum Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Rabies Antiserum Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Rabies Antiserum Sales by Type
  6. 5.2.1 Global Rabies Antiserum Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rabies Antiserum Sales by Type (2021-2032) & (K Tons)
  8. 5.2.3 Global Rabies Antiserum Sales Market Share by Type (2021-2032)
  9. 5.3 Global Rabies Antiserum Price by Type
6 Rabies Antiserum Market by Application
  1. 6.1 Global Rabies Antiserum Revenue by Application
  2. 6.1.1 Global Rabies Antiserum Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Rabies Antiserum Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Rabies Antiserum Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Rabies Antiserum Sales by Application
  6. 6.2.1 Global Rabies Antiserum Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Rabies Antiserum Sales by Application (2021-2032) & (K Tons)
  8. 6.2.3 Global Rabies Antiserum Sales Market Share by Application (2021-2032)
  9. 6.3 Global Rabies Antiserum Price by Application
7 Company Profiles
  1. 7.1 Bharat Serums
  2. 7.1.1 Bharat Serums Company Information
  3. 7.1.2 Bharat Serums Business Overview
  4. 7.1.3 Bharat Serums Rabies Antiserum Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bharat Serums Rabies Antiserum Product Portfolio
  6. 7.1.5 Bharat Serums Recent Developments
  7. 7.2 Haffkine Bio-Pharmaceutical
  8. 7.2.1 Haffkine Bio-Pharmaceutical Company Information
  9. 7.2.2 Haffkine Bio-Pharmaceutical Business Overview
  10. 7.2.3 Haffkine Bio-Pharmaceutical Rabies Antiserum Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Haffkine Bio-Pharmaceutical Rabies Antiserum Product Portfolio
  12. 7.2.5 Haffkine Bio-Pharmaceutical Recent Developments
  13. 7.3 Premium Serums
  14. 7.3.1 Premium Serums Company Information
  15. 7.3.2 Premium Serums Business Overview
  16. 7.3.3 Premium Serums Rabies Antiserum Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Premium Serums Rabies Antiserum Product Portfolio
  18. 7.3.5 Premium Serums Recent Developments
  19. 7.4 Lanzhou Institute of Biological Products
  20. 7.4.1 Lanzhou Institute of Biological Products Company Information
  21. 7.4.2 Lanzhou Institute of Biological Products Business Overview
  22. 7.4.3 Lanzhou Institute of Biological Products Rabies Antiserum Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Lanzhou Institute of Biological Products Rabies Antiserum Product Portfolio
  24. 7.4.5 Lanzhou Institute of Biological Products Recent Developments
  25. 7.5 Serum China
  26. 7.5.1 Serum China Company Information
  27. 7.5.2 Serum China Business Overview
  28. 7.5.3 Serum China Rabies Antiserum Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Serum China Rabies Antiserum Product Portfolio
  30. 7.5.5 Serum China Recent Developments
  31. 7.6 Wuhan Institute of Biological Products
  32. 7.6.1 Wuhan Institute of Biological Products Company Information
  33. 7.6.2 Wuhan Institute of Biological Products Business Overview
  34. 7.6.3 Wuhan Institute of Biological Products Rabies Antiserum Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Wuhan Institute of Biological Products Rabies Antiserum Product Portfolio
  36. 7.6.5 Wuhan Institute of Biological Products Recent Developments
8 North America
  1. 8.1 North America Rabies Antiserum Market Size by Type
  2. 8.1.1 North America Rabies Antiserum Revenue by Type (2021-2032)
  3. 8.1.2 North America Rabies Antiserum Sales by Type (2021-2032)
  4. 8.1.3 North America Rabies Antiserum Price by Type (2021-2032)
  5. 8.2 North America Rabies Antiserum Market Size by Application
  6. 8.2.1 North America Rabies Antiserum Revenue by Application (2021-2032)
  7. 8.2.2 North America Rabies Antiserum Sales by Application (2021-2032)
  8. 8.2.3 North America Rabies Antiserum Price by Application (2021-2032)
  9. 8.3 North America Rabies Antiserum Market Size by Country
  10. 8.3.1 North America Rabies Antiserum Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Rabies Antiserum Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Rabies Antiserum Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Rabies Antiserum Market Size by Type
  2. 9.1.1 Europe Rabies Antiserum Revenue by Type (2021-2032)
  3. 9.1.2 Europe Rabies Antiserum Sales by Type (2021-2032)
  4. 9.1.3 Europe Rabies Antiserum Price by Type (2021-2032)
  5. 9.2 Europe Rabies Antiserum Market Size by Application
  6. 9.2.1 Europe Rabies Antiserum Revenue by Application (2021-2032)
  7. 9.2.2 Europe Rabies Antiserum Sales by Application (2021-2032)
  8. 9.2.3 Europe Rabies Antiserum Price by Application (2021-2032)
  9. 9.3 Europe Rabies Antiserum Market Size by Country
  10. 9.3.1 Europe Rabies Antiserum Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Rabies Antiserum Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Rabies Antiserum Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Rabies Antiserum Market Size by Type
  2. 10.1.1 China Rabies Antiserum Revenue by Type (2021-2032)
  3. 10.1.2 China Rabies Antiserum Sales by Type (2021-2032)
  4. 10.1.3 China Rabies Antiserum Price by Type (2021-2032)
  5. 10.2 China Rabies Antiserum Market Size by Application
  6. 10.2.1 China Rabies Antiserum Revenue by Application (2021-2032)
  7. 10.2.2 China Rabies Antiserum Sales by Application (2021-2032)
  8. 10.2.3 China Rabies Antiserum Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rabies Antiserum Market Size by Type
  2. 11.1.1 Asia Rabies Antiserum Revenue by Type (2021-2032)
  3. 11.1.2 Asia Rabies Antiserum Sales by Type (2021-2032)
  4. 11.1.3 Asia Rabies Antiserum Price by Type (2021-2032)
  5. 11.2 Asia Rabies Antiserum Market Size by Application
  6. 11.2.1 Asia Rabies Antiserum Revenue by Application (2021-2032)
  7. 11.2.2 Asia Rabies Antiserum Sales by Application (2021-2032)
  8. 11.2.3 Asia Rabies Antiserum Price by Application (2021-2032)
  9. 11.3 Asia Rabies Antiserum Market Size by Country
  10. 11.3.1 Asia Rabies Antiserum Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Rabies Antiserum Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Rabies Antiserum Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rabies Antiserum Market Size by Type
  2. 12.1.1 SAMEA Rabies Antiserum Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Rabies Antiserum Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Rabies Antiserum Price by Type (2021-2032)
  5. 12.2 SAMEA Rabies Antiserum Market Size by Application
  6. 12.2.1 SAMEA Rabies Antiserum Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Rabies Antiserum Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Rabies Antiserum Price by Application (2021-2032)
  9. 12.3 SAMEA Rabies Antiserum Market Size by Country
  10. 12.3.1 SAMEA Rabies Antiserum Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Rabies Antiserum Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Rabies Antiserum Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Rabies Antiserum Value Chain Analysis
  2. 13.1.1 Rabies Antiserum Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Rabies Antiserum Production Mode & Process
  6. 13.2 Rabies Antiserum Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Rabies Antiserum Distributors
  9. 13.2.3 Rabies Antiserum Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst